IZZ:AU:AU-iShares China LargeCap (AUD)

ETF | Others |

Last Closing

USD 48.39

Change

+2.37 (+5.15)%

Market Cap

USD 0.32B

Volume

0.29M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.68 (+0.66%)

USD 16.05B
VGS:AU Vanguard MSCI International Sh..

-1.17 (-0.92%)

USD 8.59B
IVV:AU iShares Core S&P 500 AUD

-0.58 (-1.04%)

USD 8.26B
QUAL:AU VanEck Vectors MSCI World ex A..

-0.53 (-0.97%)

USD 6.31B
IOZ:AU Ishares Core S&P/Asx 200

+0.14 (+0.42%)

USD 6.10B
STW:AU SPDR® S&P/ASX 200 Fund

+0.45 (+0.61%)

USD 5.68B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

-0.26 (-0.64%)

USD 4.86B
NDQ:AU Betashares Nasdaq 100

-0.65 (-1.50%)

USD 4.83B
A200:AU BetaShares Australia 200

+0.88 (+0.64%)

USD 4.72B
VTS:AU Vanguard US Total Market Share..

-4.03 (-0.98%)

USD 4.70B

ETFs Containing IZZ:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 36.08% 99% N/A 86% B+
Dividend Return 2.06% 31% F 26% F
Total Return 38.14% 99% N/A 86% B+
Trailing 12 Months  
Capital Gain 16.32% 62% D 70% C-
Dividend Return 1.76% 20% F 16% F
Total Return 18.08% 55% F 68% D+
Trailing 5 Years  
Capital Gain -18.54% 10% F 48% F
Dividend Return 4.65% 9% A- 11% F
Total Return -13.88% 10% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain -10.07% N/A N/A 25% F
Dividend Return -9.15% N/A N/A 25% F
Total Return 0.92% N/A N/A 17% F
Risk Return Profile  
Volatility (Standard Deviation) 11.62% N/A N/A 88% B+
Risk Adjusted Return -78.74% N/A N/A 12% F
Market Capitalization 0.32B 53% F 73% C

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike